Pfizer is automating clinical trials through the use of Pega

Clinical trials and drug development is a lengthy and expensive business. Pharmaceutical companies can spend hundreds of millions of dollars developing just one drug for the market. And the process, as it stands, requires complicated engagement from a variety of stakeholders and isn’t currently organised in any efficient fashion.

However, that’s changing. A consortium of 19 pharmaceutical companies have come together to standardise on things that they don’t consider to be a competitive advantage, so as to further progress drug development and research. Pfizer is one of the first companies to take this on-board and is building a technology enablement platform around those standardised concepts.

That platform is being enabled by Pegasystems, which should allow the pharmaceutical group to streamline its processes, take out inefficiency and potentially introduce massive time and money savings into creating new drugs for the market.

Click here to read the full article.

©2020 PACT All Rights Reserved